论文

GUIDER 用临床指南决策流奖励提升医疗推理模型表现

Latent Decision Flow Rewards for Clinical Guideline Reasoning

精选理由

一篇医疗推理的论文:把临床指南拆成多条决策流当奖励信号,Qwen3-14B 上 MedGUIDE 准确率涨了 3.3 分,做医疗 AI 的可以看看。

论文提出 GUIDER,联合训练一个决策流控制器和一个推理策略,用于临床指南推理。控制器基于指南生成多条合理决策流,解决同一病例存在多条有效路径的 path multiplicity 问题;过程奖励以答案正确性作为门槛,缓解路径与答案不一致的 path-answer gap。在 MedGUIDE 上,GUIDER 搭配 Qwen3-14B 取得 82.5 加权准确率和 73.5 指南依从性,比最强临床强化学习基线分别高 3.3 和 3.1 分。在 AMEGA-LLM、RealMedQA、CancerGUIDE 三个域外基准上,GUIDER 也优于 CRPO、MRPO 和 FaithMed。

原文 · arXiv cs.LG

Latent Decision Flow Rewards for Clinical Guideline Reasoning

Clinical practice guidelines encode evidence-based recommendations as conditional decision flows, which makes them a natural source of process supervision for training reasoning models. Two properties of clinical reasoning make this supervision difficult to use. A decision flow consistent with a guideline does not by itself determine the correct answer for a given patient, which we call the path--answer gap, and several valid decision flows can support the same clinical decision, which we call path multiplicity. Current training approaches address parts of this problem. Answer rewards supervise the final decision, and process rewards computed against a reference flow supervise one valid decision flow per case. Supervised fine-tuning on annotated flows teaches guideline-consistent reasoning but constrains the model to one trajectory per case and can reduce answer accuracy. We introduce GUIDER, a method that jointly optimizes a decision flow controller and a reasoning policy. The controller learns to generate plausible decision flows from guideline-derived supervision, and the policy learns to generate a decision flow and a final answer for each patient case. GUIDER computes the process reward for the policy over several controller-generated flows, which accounts for path multiplicity, and gates this reward on answer correctness, which addresses the path--answer gap. Joint training allows the process supervision to evolve with the policy. On MedGUIDE, GUIDER with Qwen3-14B achieves 82.5 weighted accuracy and 73.5 guideline adherence, 3.3 and 3.1 points above the strongest clinical reinforcement learning baseline. With Qwen3-14B and Gemma4-12B backbones, GUIDER also improves over CRPO, MRPO, and FaithMed on the out-of-domain benchmarks AMEGA-LLM, RealMedQA, and CancerGUIDE.